Ubs Group Ag Oric Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 339,236 shares of ORIC stock, worth $4.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

339,236

Previous 99,006 242.64%

Holding current value

$4.44 Million

Previous $1 Million 303.09%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$9.2 - $11.93 $2.21 Million - $2.87 Million	240,230 Added 242.64%	339,236 $4.05 Million
Q2 2025 Aug 14, 2025	BUY	$4.26 - $10.55 $82,933 - $205,387	19,468 Added 24.48%	99,006 $1 Million
Q1 2025 May 13, 2025	BUY	$5.58 - $12.54 $25,718 - $57,796	4,609 Added 6.15%	79,538 $443,000
Q4 2024 Feb 14, 2025	BUY	$7.68 - $10.3 $25,912 - $34,752	3,374 Added 4.72%	74,929 $604,000
Q3 2024 Nov 14, 2024	SELL	$7.52 - $11.9 $69,575 - $110,098	-9,252 Reduced 11.45%	71,555 $733,000

Q2 2024 Aug 13, 2024	SELL	$6.63 - $12.93 $87,874 - $171,374	-13,254 Reduced 14.09%	80,807 $571,000
Q1 2024 May 13, 2024	BUY	$8.04 - $16.03 $426,827 - $851,000	53,088 Added 129.57%	94,061 $1.29 Million
Q4 2023 Feb 09, 2024	BUY	$5.41 - $9.43 $128,222 - $223,500	23,701 Added 137.22%	40,973 $376,000
Q3 2023 Nov 09, 2023	SELL	$6.05 - $9.28 $30,225 - $46,362	-4,996 Reduced 22.44%	17,272 $104,000
Q2 2023 Aug 11, 2023	BUY	$4.95 - $8.4 $110,226 - $187,051	22,268 New	22,268 $172,000
Q4 2022 Feb 08, 2023	BUY	$2.41 - $5.89 $10,363 - $25,327	4,300 Added 3233.08%	4,433 $26,000
Q3 2022 Nov 10, 2022	SELL	$3.15 - $5.24 $6,523 - $10,852	-2,071 Reduced 93.97%	133 $0
Q2 2022 Aug 10, 2022	BUY	$2.7 - $7.07 $5,950 - $15,582	2,204 New	2,204 $10,000
Q1 2022 May 16, 2022	SELL	$4.54 - $16.1 $283,291 - $1 Million	-62,399 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $437,320 - $739,183	36,413 Added 140.13%	62,399 $917,000
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $298,077 - $472,799	18,747 Added 258.97%	25,986 $544,000
Q2 2021 Aug 13, 2021	SELL	$17.37 - $25.34 $421,483 - $614,875	-24,265 Reduced 77.02%	7,239 $128,000
Q1 2021 May 12, 2021	BUY	$23.67 - $36.85 $709,555 - $1.1 Million	29,977 Added 1963.13%	31,504 $772,000
Q4 2020 Feb 11, 2021	SELL	$20.32 - $39.8 $1,686 - $3,303	-83 Reduced 5.16%	1,527 $52,000
Q3 2020 Nov 12, 2020	SELL	$19.5 - $31.26 $24,063 - $38,574	-1,234 Reduced 43.39%	1,610 $40,000
Q2 2020 Jul 31, 2020	BUY	$25.68 - $38.12 $73,033 - $108,413	2,844 New	2,844 $96,000

Others Institutions Holding ORIC

# of Institutions

156

Shares Held

105M

Call Options Held

35.1K

Put Options Held

173K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $518M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account